This patent covers our labs T3SS inhibitor screening assay wherein we infect a stable HEK293T cell line comprising an NF-kB reporter with Yersinia or Pseudomonas in the presence of the screening compound.
More information here.
A second Auerbuch Stone Lab patent was issued!